Literature DB >> 6872803

Treatment of established spinal injury-induced gastric erosions in rats with cimetidine and 16,16-dimethyl prostaglandin E2.

H H Sigman, A Gillich, L Begin.   

Abstract

Most research on the beneficial effects of pharmacologic agents on stress-induced acute gastric erosions in animals is directed at prevention. It is only the rare study that has been concerned with treatment of established erosions. A treatment model has been created using cervical cord-injured male Sprague-Dawley rats which consistently developed extensive linear erosions of the glandular portions of the stomach within 12 hr. A group of spinal rats was sacrificed after 12 hr to serve as a base of pretreatment ulcer severity. Treatment of established erosions with cimetidine 25 mg/kg every 2 hr in one group and 16,16-dimethyl prostaglandin E2 (16,16-dmPGE2) 5 micrograms/kg every 2 hr in a second group was compared to saline-treated controls. All drugs were administered by intraperitoneal route. Treatment began 12 hr after the cord transection and continued for another 12 hr at which time the rats were sacrificed. Both cimetidine and 16,16-dmPGE2 significantly inhibited the degree of erosion progression after 12 hr compared to saline controls (P less than 0.05). Acid output studies were carried out on a second set of rats subjected to the same experimental conditions with the addition of pyloric ligation 6 hr prior to sacrifice. A significant decrease in acid output (P less than 0.05) occurred only in the cimetidine group compared to control. It is concluded that both cimetidine and 16,16-dmPGE2 can arrest the progression of erosive changes in the stomach after cervical cord injury in rats. This is likely related to acid reduction by cimetidine and cytoprotection by prostaglandin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872803     DOI: 10.1007/bf01312561

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Electrophysiological effects of burimamide and 16,16-dimethyl prostaglandin E2 on the canine gastric mucosa.

Authors:  J C Bowen; Y J Kuo; W Pawlik; D Williams; L L Shanbour; E D Jacobson
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

2.  Prostaglandin cytoprotection of gastric mucosa.

Authors:  T K Chaudhury; E D Jacobson
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

3.  Cytoprotection by prostaglandins.

Authors:  A Robert
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

Review 4.  Stress and the acute gastric mucosal lesion.

Authors:  F G Moody; L Y Cheung; M A Simons; C Zalewsky
Journal:  Am J Dig Dis       Date:  1976-02

5.  Prevention of sepsis-induced gastric lesions in dogs by cimetidine via inhibition of gastric secretion and by prostaglandin via cytoprotection.

Authors:  P Odonkor; C Mowat; H S Himal
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

6.  Cimetidine in acute gastric mucosal bleeding: results of a double-blind randomized trial.

Authors:  J Terés; J M Bordas; A Rimola; C Bru; J Rodes
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

7.  Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins.

Authors:  J P Bolton; D Palmer; M M Cohen
Journal:  Am J Dig Dis       Date:  1978-04

8.  The effect of prostaglandin E2, 15-methyl prostaglandin E2, and metiamide on established canine gastric mucosal barrier damage.

Authors:  J P Bolton; M M Cohen
Journal:  Surgery       Date:  1979-03       Impact factor: 3.982

9.  Effects of antacids, cimetidine, and 16,16-dimethyl prostaglandin E2 on acute gastric erosions in a spinal rat.

Authors:  H H Sigman; A Gillich
Journal:  Dig Dis Sci       Date:  1982-03       Impact factor: 3.199

10.  Effect of 16, 16-dimethyl PGE2 on resting and histamine-stimulated gastric mucosal blood flow.

Authors:  T A Miller; J M Henagan; A Robert
Journal:  Dig Dis Sci       Date:  1980-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.